Intelligent Medicine Acquisition Corp.
IQMDW
NASDAQ Global Market0.00
USD
-0.03
- -
CIK
0001850051
CUSIP
45828D114
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-99.50
76.60
5Y
-99.50
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Gregory C. Simon
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 9001 Burdette Road Bethesda MD United States of America 20817
- IPO Date
- Dec 27, 2021
- CIK
- 0001850051
- Similar Companies
- Business
- Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW) operates as a blank check company whose principal activity centers on pursuing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more life science companies leveraging artificial intelligence, machine learning, and big data for drug discovery and development; it maintains no significant ongoing operations or revenue generation. Incorporated in 2021 and headquartered in Bethesda, Maryland, the company raised $207 million in an upsized initial public offering in November 2021, placing funds into a trust account for deployment toward a target acquisition, with warrants trading separately from December 2021; it targeted the global healthcare and biotechnology sectors without current subsidiaries or parent affiliations. In April 2023, Intelligent Medicine Acquisition Corp. announced its dissolution and liquidation after failing to complete an initial business combination within the required timeframe, redeeming all outstanding Class A public shares at approximately $11.22 per share, canceling the shares post-redemption, suspending Nasdaq trading effective April 27, 2023, and allowing warrants to expire worthless, marking its delisting and cessation of active operations.